ArticleClinical and experimental rheumatology

Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro.

Monique Hinchcliff et al.PubMed ↗Full text ↗

No numbers read from the abstract.